• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除治疗黏液型细支气管肺泡癌患者。

Surgical resection for patients with mucinous bronchioloalveolar carcinoma.

机构信息

Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan.

出版信息

Asian J Surg. 2010 Apr;33(2):89-93. doi: 10.1016/S1015-9584(10)60015-2.

DOI:10.1016/S1015-9584(10)60015-2
PMID:21029945
Abstract

BACKGROUND

The clinical features of mucinous bronchioloalveolar carcinoma (BAC) have remained unclear due to the low incidence of this disease. This study investigated the clinicopathological features and the surgical outcome in patients with mucinous BAC.

METHODS

We clinicopathologically evaluated 782 patients who underwent resection for nonsmall cell carcinoma between 1999 and 2008, of whom, 13 (1.6%) demonstrated to have mucinous BAC.

RESULTS

The patients with mucinous BAC included six men and seven women. The mean age was 69.1 years (range: 55-78 years). Eight patients (61.5%) had a smoking habit. No patients had any subjective symptoms. The tumour diameter ranged from 1.2 cm to 10 cm. The surgical procedures included 11 lobectomies, and two partial resections of affected lobes. The pathological stage was IA in eight patients, IB in two, IIA in two, and IIIA in one. None of the patients had lymph node metastases or lymphovascular invasion. The overall postoperative 5-year survival rate was 52.5%. The 5-year survival rate according to tumour diameter was 100% in patients with tumours ≤ 3 cm, and 25.1% in patients with tumours > 3 cm. Two patients died due to pulmonary metastases, and one died from carcinomatous pleuritis and pulmonary metastases.

CONCLUSION

Patients with small mucinous BAC (≤ 3 cm) in diameter showed excellent prognosis after surgical resection. However, mucinous BAC > 3 cm in diameter tended to recur with pulmonary metastasis.

摘要

背景

由于该病发病率低,黏液性细支气管肺泡癌(BAC)的临床特征仍不清楚。本研究调查了黏液性 BAC 患者的临床病理特征和手术结果。

方法

我们对 1999 年至 2008 年间因非小细胞癌行切除术的 782 例患者进行了临床病理评估,其中 13 例(1.6%)为黏液性 BAC。

结果

黏液性 BAC 患者包括 6 例男性和 7 例女性。平均年龄为 69.1 岁(范围:55-78 岁)。8 例(61.5%)有吸烟史。无患者有任何主观症状。肿瘤直径为 1.2-10cm。手术方式包括 11 例肺叶切除术和 2 例受累肺叶部分切除术。病理分期为 IA 期 8 例,IB 期 2 例,IIA 期 2 例,IIIA 期 1 例。无患者有淋巴结转移或脉管侵犯。所有患者的总体术后 5 年生存率为 52.5%。肿瘤直径≤3cm 的患者 5 年生存率为 100%,肿瘤直径>3cm 的患者 5 年生存率为 25.1%。2 例患者死于肺转移,1 例死于癌性胸膜炎和肺转移。

结论

直径≤3cm 的小黏液性 BAC 患者手术后预后良好。然而,直径>3cm 的黏液性 BAC 倾向于复发并发生肺转移。

相似文献

1
Surgical resection for patients with mucinous bronchioloalveolar carcinoma.手术切除治疗黏液型细支气管肺泡癌患者。
Asian J Surg. 2010 Apr;33(2):89-93. doi: 10.1016/S1015-9584(10)60015-2.
2
Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.直径3厘米及以下的肺细支气管肺泡癌:预后评估
Ann Thorac Surg. 2004 Nov;78(5):1728-33. doi: 10.1016/j.athoracsur.2004.05.017.
3
A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.一项基于单个机构的回顾性研究:手术治疗的肺细支气管肺泡腺癌:临床病理分析、分子特征以及常规实践中的可能陷阱。
J Thorac Oncol. 2010 Jun;5(6):830-6. doi: 10.1097/jto.0b013e3181d60ff5.
4
Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival.细支气管肺泡癌:发病率、外科治疗与生存率
Eur J Cardiothorac Surg. 2003 May;23(5):818-23. doi: 10.1016/s1010-7940(03)00084-8.
5
Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma.手术治疗的细支气管肺泡癌患者的放射学和病理学预后因素评估。
Eur J Cardiothorac Surg. 2001 Aug;20(2):367-71. doi: 10.1016/s1010-7940(01)00733-3.
6
Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.非黏液型和黏液型腺癌伴细支气管肺泡癌特征的亚型在生物标志物表达和对吉非替尼的反应方面存在差异。
Lung Cancer. 2010 May;68(2):185-91. doi: 10.1016/j.lungcan.2009.05.021. Epub 2009 Jul 5.
7
[The occurrence of bronchioloalveolar lung cancer among our patients].[我们患者中细支气管肺泡肺癌的发生情况]
Magy Onkol. 2003;47(4):349-53. Epub 2004 Jan 11.
8
[Prognosis of resected stage I bronchioloalveolar carcinoma of the lung].[肺切除的Ⅰ期细支气管肺泡癌的预后]
Kyobu Geka. 2004 Jun;57(6):440-3.
9
Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung.Ⅰ期纯细支气管肺泡癌:复发、生存情况及与肺腺癌的比较
Eur J Cardiothorac Surg. 2003 Mar;23(3):409-14. doi: 10.1016/s1010-7940(02)00830-8.
10
[Bronchioalveolar carcinoma: five year survival].
Medicina (B Aires). 2006;66(4):313-8.

引用本文的文献

1
Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.基于不同影像学亚型的原发性肺黏液腺癌的临床病理特征和生存结局。
Ann Surg Oncol. 2024 Jan;31(1):167-177. doi: 10.1245/s10434-023-14193-w. Epub 2023 Nov 5.
2
Differential diagnosis of pulmonary nodular mucinous adenocarcinoma and tuberculoma with dynamic CT: a retrospective study.动态CT对肺结节状黏液腺癌与结核瘤的鉴别诊断:一项回顾性研究
J Thorac Dis. 2022 Apr;14(4):1225-1231. doi: 10.21037/jtd-22-372.
3
A novel nomogram to predict the overall survival of patients with colloid adenocarcinoma of the lung.
一种预测肺黏液腺癌患者总生存期的新型列线图。
Transl Cancer Res. 2021 Feb;10(2):759-767. doi: 10.21037/tcr-20-2795.
4
Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database.基于监测、流行病学和最终结果(SEER)数据库开发和验证预测肺浸润性黏液性腺癌生存的列线图。
BMC Cancer. 2021 Feb 10;21(1):148. doi: 10.1186/s12885-021-07811-x.
5
Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study.浸润性黏液腺癌对手术切除后肺癌特异性生存的影响:一项基于人群的研究。
J Thorac Dis. 2018 Jun;10(6):3595-3608. doi: 10.21037/jtd.2018.06.09.
6
Fluorodeoxyglucose-positron emission tomography/computed tomography imaging features of colloid adenocarcinoma of the lung: a case report.肺黏液腺癌的氟脱氧葡萄糖-正电子发射断层扫描/计算机断层扫描成像特征:病例报告
J Med Case Rep. 2017 Jul 27;11(1):202. doi: 10.1186/s13256-017-1380-6.
7
Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.非鳞屑状浸润模式的大小可预测肺黏液腺癌的复发:188例切除病例的形态学分析及浸润标准的重新评估
J Pathol Transl Med. 2017 Jan;51(1):56-68. doi: 10.4132/jptm.2016.09.17. Epub 2016 Oct 16.
8
Prognosis and status of lymph node involvement in patients with adenocarcinoma in situ and minimally invasive adenocarcinoma-a systematic literature review and pooled-data analysis.原位腺癌和微浸润腺癌患者淋巴结受累的预后及状况——一项系统文献综述和汇总数据分析
J Thorac Dis. 2015 Nov;7(11):2003-9. doi: 10.3978/j.issn.2072-1439.2015.11.48.
9
Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.肺腺癌:分子生物学、治疗及国际肺癌研究协会/美国胸科学会/欧洲呼吸学会分类的最新进展的影响
J Thorac Dis. 2014 Oct;6(Suppl 5):S502-25. doi: 10.3978/j.issn.2072-1439.2014.05.19.
10
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.